KR20130081948A - Kit and method for detecting new influenza a virus - Google Patents
Kit and method for detecting new influenza a virus Download PDFInfo
- Publication number
- KR20130081948A KR20130081948A KR1020120003075A KR20120003075A KR20130081948A KR 20130081948 A KR20130081948 A KR 20130081948A KR 1020120003075 A KR1020120003075 A KR 1020120003075A KR 20120003075 A KR20120003075 A KR 20120003075A KR 20130081948 A KR20130081948 A KR 20130081948A
- Authority
- KR
- South Korea
- Prior art keywords
- syto
- pcr
- light
- virus
- influenza
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
Abstract
The present invention relates to a kit for detecting influenza and a method for simultaneously detecting several types of influenza using the same. Using the kit for detecting influenza according to one embodiment, it is possible to efficiently detect several kinds of swine flu simultaneously.
Description
The present invention relates to a kit for influenza A virus detection and a method for detecting influenza A virus in real time using the same.
Since influenza A virus spreads rapidly through the respiratory tract mainly due to coughing or sneezing of an infected person, there is a need for a method for quickly and economically confirming the presence of influenza A virus in order to prevent the spread of rapid disease. Representative diagnostic methods of influenza A virus infection include commercially available enzyme immuno-assay (EIA), which detects antibodies that bind to recombinant influenza A virus proteins or peptides. Although immunological methods using antibodies can diagnose diseases with high accuracy, a large amount of samples are required, and in order to produce antibodies for each diagnosis, it is essential to produce proteins or peptides of viruses characteristic of all diseases. High antibody production costs are required. In addition, due to the nature of the protein, there are many difficulties in storage and use, and only one type or limited type of disease can be diagnosed at a time. Other methods include diagnosing diseases using cell cultures and DNA probes, but they all require a high level of skill and time. In order to remedy this drawback, various disease diagnosis kits using the PCR method have begun to be researched and developed. Diagnostic kits using PCR methods are increasing in demand in various fields due to their high accuracy, simplicity and rapidity.
In particular, the real-time PCR method, which is widely used in recent years, is a method to observe the increase of the PCR amplification product in real time in every cycle of the PCR and to detect and quantify the fluorescent substance reacting with the PCR amplification product. This method eliminates the need for additional electrophoresis, has excellent accuracy and sensitivity, has high recall, and can be automated, as compared with conventional PCR method after completion of the final step and staining on gel to confirm PCR amplification products after electrophoresis And the result can be quantified, and it is quick and easy, and it is excellent in biological safety due to harmful problems such as contamination by EtBr (Ethidium Bromide) and irradiation with ultraviolet ray, and it is possible to automatically check whether the specific gene is amplified There are advantages. Thus, quantitative results with high specificity, not qualitative results such as PCR or antigen / antibody, can be identified through real-time PCR methods. In addition, since the probe labeled with a fluorescent marker is used, the result can be confirmed even with a sample smaller than the amount of the sample used for the DNA chip or the antigen / antibody reaction.
Therefore, there is a need for the development of a method for detecting influenza A virus and a detection kit using a real-time PCR method in order to quickly and accurately diagnose the influenza A virus in a sample.
One embodiment is to provide a kit for influenza A virus detection comprising a primer set for detecting several types of influenza A virus in a PCR chip.
Another embodiment provides a method for detecting influenza A virus in real time using a kit for influenza A virus detection.
An aspect includes a first plate; A second plate disposed at an upper portion of the first plate and having at least one through-opening channel; And a third plate disposed on the upper portion of the second plate and having a through-hole inlet formed in one region of each of the at least one through-hole opening channel and a through-hole outlet portion formed in another region of the at least one through- In the at least one through-aperture channel,
(a) Matrix gene of a novel influenza virus consisting of a primer comprising at least 15 consecutive nucleotides of SEQ ID NO: 1 and a primer comprising at least 15 consecutive nucleotides of SEQ ID NO: GenBank ID number: GQ131025) set of primers for detecting;
(b) Hemagglutinin of a novel influenza virus consisting of a primer comprising at least 15 consecutive nucleotides in SEQ ID NO: 3 and a primer comprising at least 15 consecutive nucleotides in SEQ ID NO: 4 ) Primer set for detecting gene (GenBank ID number: GQ131023);
(c) Neuraminidase of a novel influenza virus consisting of a primer comprising at least 15 consecutive nucleotides of SEQ ID NO: 5 and a primer comprising at least 15 consecutive nucleotides of SEQ ID NO: 6 A kit for detecting influenza A virus, each kit comprising at least one primer set selected from the group consisting of a primer set for detecting a gene (GenBank ID number: GQ1312185).
The term primer is a single stranded oligonucleotide that can serve as an initiation of template-directed DNA synthesis under suitable conditions (ie, four different nucleoside triphosphates and polymerases) in suitable buffers at suitable temperatures. Means. Suitable lengths of primers are typically 15 to 30 nucleotides, although varying depending on various factors, such as temperature and the use of the primer. Short primers may generally require lower temperatures to form a hybridization complex that is sufficiently stable with the template. The terms " forward primer "and" reverse primer "refer to primers that bind respectively to the 3 'and 5' ends of a constant region of a template amplified by a polymerase chain reaction. The sequence of the primer does not need to have a sequence completely complementary to a partial sequence of the template, and it is sufficient if the primer has sufficient complementarity within a range capable of hybridizing with the template and acting as a primer. Therefore, the primer set according to one embodiment does not need to have a perfectly complementary sequence to a nucleotide sequence that is a template, and it is interpreted that sufficient complementarity within a range capable of hybridizing to the nucleotide sequence and acting as a primer is sufficient. The design of such a primer can be easily carried out by those skilled in the art with reference to the nucleotide sequence of a polynucleotide to be a template. For example, a primer design program (for example, PRIMER 3, VectorNTI program) have. On the other hand, the primer according to one embodiment is hybridized or annealed at one site of the template to form a double-stranded structure. Conditions for nucleic acid hybridization suitable for forming such double chain structures are described in Joseph Sambrook, et al., Molecular . Cloning , A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (2001) and Haymes, BD, et al., Nucleic Acid Hybridization , A Practical Approach , IRL Press, Washington, DC (1985). For example, the primer may comprise at least 10 or at least 15 contiguous nucleotides in any one of SEQ ID NO: 1 to SEQ ID NO: 6, wherein the primer is selected from SEQ ID NO: 1 to SEQ ID NO: 6 It may be an oligonucleotide having either base sequence.
According to one embodiment, the at least one primer set comprises a first plate; A second plate disposed at an upper portion of the first plate and having at least one through-opening channel; And a third plate disposed on the upper portion of the second plate and having a through-hole inlet formed in one region of each of the at least one through-hole opening channel and a through-hole outlet portion formed in another region of the at least one through- Is included in the at least one through-aperture channel. For example, if a PCR chip for simultaneously detecting 15 types of primers is prepared, a PCR chip can be fabricated so that a total of 17 through-opening channels are included in the PCR chip, including a positive control group and a negative control group. Meanwhile, according to one embodiment, the PCR chip may be implemented with a light-transmitting material.
According to one embodiment, the first plate and the third plate are made of a material selected from the group consisting of polydimethylsiloxane, cycle olefin copolymer, polymethylmetharcylate, polycarbonate, polypropylene Wherein the second plate is made of a material selected from the group consisting of polypropylene carbonate, polyether sulfone, and polyethylene terephthalate and combinations thereof, and the second plate is made of a material selected from the group consisting of polymethyl methacrylate, polycarbonate, Polyamide, polyethylene, polypropylene, polyphenylene ether, polystyrene, polyoxymethylene, polyetheretherketone, polyetheretherketone, polyetheretherketone, polyetheretherketone, , Polytetrafluoroethylene, polytetrafluoroethylene, Selected from the group consisting of polyvinylchloride, polyvinylidene fluoride, polybutyleneterephthalate, fluorinated ethylenepropylene, perfluoralkoxyalkane, and combinations thereof. Or a thermosetting resin or a thermosetting resin material.
According to one embodiment, the through opening inlet of the third plate is from 0.01 mm to 10 mm in diameter, the through opening outlet is from 0.01 mm to 10 mm in diameter, and the thickness of the third plate is from 0.05 mm to 5 mm, The thickness of the second plate may be 10 μm to 1000 μm, the width of the through opening channel may be 0.01 mm to 10 mm, and the length of the through opening channel may be 10 mm to 100 mm.
According to one embodiment, the through-hole inlet portion of the third plate is 1.0 mm to 3.0 mm in diameter, the through-hole outlet portion has a diameter of 1.0 mm to 1.5 mm, the third plate has a thickness of 0.1 mm to 2 mm, Wherein the thickness of the second plate is 100 占 퐉 to 200 占 퐉, the width of the through-hole opening channel is 0.5 mm to 3 mm, and the length of the through-hole opening channel is 20 mm to 60 mm.
This can be controlled according to the amount of the PCR reaction solution contained in the through-hole opening channel.
According to one embodiment, the influenza A virus detectable from the kit may be, for example, but not limited to, influenza A virus subtype H1N1.
According to one embodiment, the kit may further comprise a mixture comprising dATP, dCTP, dGTP and dTTP, a DNA polymerase and a detectable label inside the through-channel. The DNA polymerase is for example Thermus aquaticus (Taq), Thermus thermophilus (Tth), Thermus filiformis , Thermis flavus , Thermococcus literalis or Pyrococcus furiosus Heat stable DNA polymerase obtained from (Pfu).
The term "detectable label" refers to an atom or molecule that specifically detects a molecule containing a label, among molecules of the same type without a label, such detectable labels being, for example, Alexa Fluor 350, Alexa Fluor 430, Alexa Fluor 660, Alexa Fluor 680, Cy2, Cy3.18, Cy3.5, Cy3.5, Alexa Fluor 430, Cy3, Cy5.18, Cy5.5, Cy5, Cy7, Oregon Green, Oregon Green 488-X, Oregon Green, Oregon Green 488, Oregon Green 500, Oregon Green 514, SYTO 11, SYTO 12, SYTO 13, SYTO 14, SYTO 15, SYTO 16, SYTO 17, SYTO 18, SYTO 20, SYTO 21, SYTO 22, SYTO 23, SYTO 24, SYTO 25, SYTO 40, SYTO 41, SYTO 42, SYTO 43, SYTO 44, SYTO 45, SYTO 59 SYTOX Blue, SYTOX Green, SYTOX Orange, SYBR Green, YO-PRO-100, SYTO 60, SYTO 61, SYTO 62, SYTO 63, SYTO 64, SYTO 80, SYTO 81, SYTO 82, SYTO 83, SYTO 84, SYTO 85, 1, YO-PRO-3, YOYO-1, YOYO-3 and thiazo le orange), but the present invention is not limited thereto. In addition, the kit may include a buffer solution in the through-channel. Buffer solutions are compounds that are added to an amplification reaction that modifies the stability, activity, and / or lifetime of one or more components of the amplification reaction by modulating the pH of the amplification reaction. Such buffer solutions are well known in the art, For example, it may be, but is not limited to, Tris, Tricine, MOPS, or HEPES. In addition, the kit may comprise a dNTP mixture (dATP, dCTP, dGTP, dTTP) and a DNA polymerase joiner.
According to one embodiment, the PCR chip may have two or more through opening channels, specifically, two or more through 17 or less through opening channels, which may be arbitrarily selected according to the type of influenza A virus or gene to be detected. Controllability is as described above.
Another aspect includes injecting a subject sample suspected of being infected with influenza A virus into one or more through opening inlets of the kit to perform real time PCR; And it provides a real-time detection method of influenza A virus comprising the step of confirming the presence or absence of influenza A virus in the target sample from the real-time PCR results.
The real-time detection method of the influenza A virus will be described in detail for each step as follows.
First, the method may be performed by injecting a target sample suspected of influenza A virus infection into one or more through-opening inlets of the kit to perform real-time PCR. In this step, the target sample suspected of influenza A virus infection may be first synthesized cDNA from the RNA of the sample. Since influenza viruses are viruses with RNA in the genome, reverse transcription is performed from the genomic RNA of the virus, from which the cDNA is synthesized, in order to obtain the template necessary for performing PCR to detect it. Reverse transcription reactions can be carried out using a variety of reverse transcriptase enzymes well known in the art, for example reverse transcriptase enzymes such as Invtrogen's SuperScript series and kits comprising the same. Thereafter, the synthesized cDNA may be injected into one or more through opening inlets of the kit to perform real-time PCR.
According to one embodiment, the real time PCR may be performed in a PCR device comprising a thermal block, a light transmissive column block, or two column blocks, respectively. The PCR device including the light-transmitting thermal block or two thermal blocks is manufactured by the present inventor and can perform real-time PCR, and a detailed description of the device will be given later.
The detection method according to one embodiment may be applied to a sample that is expected to be infected with influenza A virus. The sample includes, but is not limited to, bodily fluids such as cultured cells, blood, saliva, and the like.
According to one embodiment, the real-time PCR reaction can be performed using a real-time PCR apparatus developed by the present inventor. The real-time PCR method is a method for detecting and quantifying fluorescence which appears in real time every PCR cycle by the principle of DNA polymerase and FRET using a device in which a thermal cycler and a spectrophotometer are integrated. This method can distinguish specific amplification products from nonspecific amplification products and can easily obtain the results in an automated manner. In the method for detecting influenza A virus according to one embodiment, the real-time PCR reaction may be carried out under conventional conditions known in the art, for example, initial denaturation was performed at 95 ° C. for 10 minutes. After that, denaturation may be performed at 95 ° C. for 5 seconds, and annealing and elongation of the primer are performed 30 times at 72 ° C. for 20 seconds in total.
Finally, the presence or absence of influenza A virus in the target sample may be included from the real-time PCR result.
The presence or absence of the influenza A virus is C t, which is the number of cycles when a certain amount of PCR amplification products is amplified from a curve displayed by detecting a fluorescent labeling agent labeled on the PCR product amplified in the real time PCR process. Can be confirmed by calculating a value. The C t The calculation of the value can be performed automatically by the program included in the real-time PCR device.
According to one embodiment, the influenza A virus may be, but is not limited to, influenza A virus subtype H1N1.
Using an influenza A virus detection kit according to one embodiment, it is possible to detect influenza A virus in real time.
1 shows a light transmissive column block included in a PCR device according to an embodiment of the present invention.
Figure 2a shows the thermal distribution of the thermal block included in the conventional PCR device.
Figure 2B shows the thermal distribution of the light transmissive thermal block included in the PCR device according to one embodiment of the present invention.
FIG. 2C shows a temperature change with time of the light-transmitting thermal block included in the PCR apparatus according to an embodiment of the present invention.
FIG. 3A shows a light-transmitting thermal block included in a PCR apparatus according to an embodiment of the present invention in which a light absorbing layer is disposed in contact with a lower surface of a substrate, FIG. 3B illustrates a light- FIG. 3C shows a light-transmissive thermal block included in the PCR device according to one embodiment of the present invention. FIG. 3C is a schematic view of a light- Transparent antistatic layer included in the PCR device according to one embodiment of the present invention in which a light reflection preventing layer for contacting the light blocking layer is disposed in contact with the upper portion of the insulating protective layer.
4 shows that a PCR chip is arranged on a light-transmissive column block of a PCR apparatus according to an embodiment of the present invention including a light-providing portion and a light detecting portion.
Figure 5 shows the light providing portion of the PCR device according to one embodiment of the present invention in more detail.
FIG. 6 shows the optical detector of the PCR apparatus according to one embodiment of the present invention in more detail.
Figure 7 shows the optical path by a dichroic filter included in a PCR device according to one embodiment of the present invention.
8 shows a cross section of a light-transmitting PCR chip according to another embodiment of the present invention.
9 shows a cross section of a light-transmitting PCR chip according to another embodiment of the present invention in which a double-sided adhesive or a thermoplastic resin or a thermosetting resin is treated.
Figure 10 shows a PCR device comprising two column blocks according to another embodiment of the present invention.
11 shows each step of nucleic acid amplification reaction by movement of a chip holder of a PCR apparatus including two column blocks according to another embodiment of the present invention.
FIG. 12 shows a step of observing a nucleic acid amplification reaction in real time using a PCR apparatus including two column blocks according to another embodiment of the present invention.
13 is a matrix gene (GenBank ID number: GQ131025), hemagglutinin gene (GenBank ID number: GQ131023) and neurami using the kit for influenza A virus according to one embodiment of the present invention. The results of the simultaneous detection of the Neuraminidase gene (GenBank ID number: GQ1312185) are shown.
Hereinafter, one or more embodiments will be described in more detail by way of examples. However, these embodiments are intended to illustrate one or more embodiments, and the scope of the invention is not limited to these embodiments.
1 shows a light-transmissive
A PCR apparatus according to an embodiment of the present invention includes a
The
The
The insulating
The
The light-transmissive
The PCR device including the light-
3A shows a light-transmitting
In general, it is possible to measure and analyze the occurrence and extent of PCR products in real time using a fluorescent material while performing a PCR. Such PCR is called real time PCR. In the reaction, a fluorescent material as well as a reagent required for a PCR reaction is added to a PCR chip, and the fluorescent material emits light by light of a specific wavelength according to the generation of a PCR product, thereby inducing a measurable optical signal. Therefore, in order to accurately monitor the PCR product in real time, it is necessary to increase the sensing efficiency of the optical signal as much as possible. Since the light transmissive
4 shows that a PCR chip is arranged on a light-transmissive column block of a PCR apparatus according to an embodiment of the present invention including a light-providing portion and a light detecting portion.
According to FIG. 4, the PCR apparatus includes a
FIG. 5 illustrates the
According to FIG. 5, the
6 shows the
According to FIG. 6, the
Figure 7 shows the optical path by the dichroic filter 400 included in the PCR device according to one embodiment of the present invention.
According to FIG. 7, the PCR apparatus may adjust one or more directions of light so that the light emitted from the
Fig. 8 shows a cross-section of a light-
According to Figure 8, a light-
The
The
The
The
9 shows a light-transmitting PCR chip according to another embodiment of the present invention in which a double-sided adhesive or a thermoplastic resin or a
The light-transmissive PCR chip (100) is mechanically processed to form a through-opening inlet (931) and a through-opening outlet (932) to provide a third plate (930); The
The through
Figure 10 shows a PCR device comprising two column blocks according to another embodiment of the present invention.
The PCR device comprising the two column blocks comprises a
The PCR device including the two column blocks may complete the first cycle by performing the two steps consisting of the extension step and the annealing and extension (or amplification) steps.
The PCR device including the two column blocks includes a
The
The
In the
The
The
The
The PCR device including the two column blocks can be moved left and right and / or up and down by the driving means 1500 on the
The
The
The driving means 1500 may include all means for making the
11 shows each step of nucleic acid amplification reaction by movement of a chip holder of a PCR apparatus including two column blocks according to another embodiment of the present invention.
The nucleic acid amplification reaction by the PCR apparatus including the two column blocks is performed by the following steps. First, an oligonucleotide primer, a DNA polymerase, a deoxyribonucleotide triphosphate (dNTP) having a sequence complementary to a specific nucleotide sequence to be amplified, a nucleic acid such as double-stranded DNA, , And a PCR reaction buffer are introduced into the
The
Thereafter, the
Thereafter, the
Lastly, the
FIG. 12 shows a step of observing a nucleic acid amplification reaction in real time using a PCR apparatus including two column blocks according to another embodiment of the present invention.
The PCR apparatus including the two column blocks may further include a
By the arrangement of the
The step of detecting the amplification degree of the nucleic acid in the
Therefore, according to the PCR apparatus including the two thermal blocks, the reaction result by amplification of nucleic acid (phosphorescent substance bound) in the reaction chamber (or channel) during each cycle of the PCR reaction is performed. By monitoring in real time, the amount of target nucleic acid contained in the initial reaction sample can be measured and analyzed in real time.
Example 1: influenza A virus cDNA synthesis
The genomic RNA of Influenza A virus H1N1 was distributed from the Centers for Disease Control. The reverse transcription reaction solution was prepared using Invitrogen's SupterScript III First-strand Synthesis System for RT-PCR kit together with the genomic RNA that was distributed, the reverse transcription reaction was performed, and cDNA was synthesized. The composition of the reverse transcription reaction solution and cDNA synthesis conditions used in the reverse transcription reaction are shown in Tables 1 and 2 below.
Example 2: for influenza A virus detection primer Production and synthesis
The primers used for real-time detection of influenza A virus were made through
In order to confirm specific detection of primers against influenza A virus, PCR was performed using the cDNA of the influenza A virus synthesized in Example 1 as a template. Table 4 and Table 6 show the composition of the PCR reaction solution used in the PCR reaction and the PCR conditions performed. Each PCR reaction solution was added distilled water to the following composition so that the total volume was 50 μl.
(2 steps, 30 cycles)
After PCR, 3 ul of each reaction solution was subjected to electrophoresis on 1% agarose gel to identify the PCR reaction product. Thus, specific primers present in each influenza A virus were identified by the primer sets shown in Table 3 above. After detection, the remaining 47 ul was subjected to electrophoresis on 1% agarose gel, and then a DNA fragment of the PCR reaction product was extracted using a gel extraction kit (Invitrogen). Each of the extracted DNA fragments was cloned into a StrataClone PCR cloning kit (Stratagene). Each of the cloned vectors was transformed into E. coli and plated on LB plates containing ampicillin / X-gal / IPTG and incubated at 37 ° C. Then, only the colonies containing the cloned vector so as to contain the PCR amplification product were selected and cultured in LB medium. Then, the plasmid DNA was extracted using plasmid DNA miniprep kit (Qiagen). The extracted plasmid DNA was commissioned by Cosmojin Tech Co., Ltd. to analyze the nucleotide sequence of the cloned gene. As a result, each base sequence was confirmed to match the base sequence of the gene to be amplified.
Example 3: Light transmittance Heat block Or two Heat block Each containing PCR Device and Light transmittance PCR Real-time Detection of Influenza A Virus Using a Chip
A real-time PCR device prepared by the present inventors using a primer set capable of detecting an influenza A virus as described in Table 3 as a template and influenza A virus synthesized in Example 1 (optical Real time PCR was performed using a PCR device including a transparent heat block) and a light transmitting PCR chip. The composition of the reaction solution for the real time PCR and the reaction conditions of the real time PCR are described in Tables 6 and 7 below. Each PCR reaction solution was made to have a total volume of 12 ul by adding distilled water to the following composition, and the reaction solution for detecting different types of influenza A virus was injected into the through-opening inlets of different through-opening channels in the PCR chip. . In this example, six through-open channels were arranged on the PCR chip to simultaneously detect several genes of six types of influenza A virus. As a negative control template, Salmonella, a food poisoning bacterium that is not associated with influenza A virus instead of cDNA The genome DNA of enterica was used.
(2 steps, 30 cycles)
As shown in Figure 13, it was confirmed that each influenza A virus can be detected in real time using the kit of the present invention according to one embodiment. In addition, it was confirmed from the electrophoretic photograph of the PCR amplification product of FIG. 13 that the gene of each influenza A virus was specifically detected by the primer set.
<110> NANOBIOSYS INC. <120> Kit and method for detecting new influenza A virus <130> PN089983 <160> 6 <170> Kopatentin 1.71 <210> 1 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> forward primer (NBS-M-F) <400> 1 aagccgagat cgcgcagaga ctgga 25 <210> 2 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> reverse primer (NBS-M-R) <400> 2 actgggcacg gtgagcgtga acaca 25 <210> 3 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> forward primer (NBS-HA-F) <400> 3 gctggatcct gggaaatcca gagtg 25 <210> 4 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> reverse primer (NBS-HA-R) <400> 4 gttcgagtca tgattgggcc atgaa 25 <210> 5 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> forward primer (NBS-NA-F) <400> 5 atcagagggc gacccaaaga gaaca 25 <210> 6 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> reverse primer (NBS-NA-R) <400> 6 taaatggcaa ctcagcaccg tctgg 25
Claims (11)
(a) Matrix gene of a novel influenza virus consisting of a primer comprising at least 15 consecutive nucleotides of SEQ ID NO: 1 and a primer comprising at least 15 consecutive nucleotides of SEQ ID NO: GenBank ID number: GQ131025) set of primers for detecting;
(b) Hemagglutinin of a novel influenza virus consisting of a primer comprising at least 15 consecutive nucleotides in SEQ ID NO: 3 and a primer comprising at least 15 consecutive nucleotides in SEQ ID NO: 4 ) Primer set for detecting gene (GenBank ID number: GQ131023);
(c) Neuraminidase of a novel influenza virus consisting of a primer comprising at least 15 consecutive nucleotides of SEQ ID NO: 5 and a primer comprising at least 15 consecutive nucleotides of SEQ ID NO: 6 ) A kit for detecting influenza A virus, each kit comprising one or more primer sets selected from the group consisting of primer sets for detecting a gene (GenBank ID number: GQ1312185).
Checking the presence or absence of influenza A virus in the target sample from the real-time PCR results.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120003075A KR20130081948A (en) | 2012-01-10 | 2012-01-10 | Kit and method for detecting new influenza a virus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120003075A KR20130081948A (en) | 2012-01-10 | 2012-01-10 | Kit and method for detecting new influenza a virus |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20130081948A true KR20130081948A (en) | 2013-07-18 |
Family
ID=48993448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120003075A KR20130081948A (en) | 2012-01-10 | 2012-01-10 | Kit and method for detecting new influenza a virus |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20130081948A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150022263A (en) | 2013-08-22 | 2015-03-04 | 고려대학교 산학협력단 | Kit for determining infection of influenza A virus |
KR20150022262A (en) | 2013-08-22 | 2015-03-04 | 고려대학교 산학협력단 | Kit for determining infection of influenza A virus |
-
2012
- 2012-01-10 KR KR1020120003075A patent/KR20130081948A/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150022263A (en) | 2013-08-22 | 2015-03-04 | 고려대학교 산학협력단 | Kit for determining infection of influenza A virus |
KR20150022262A (en) | 2013-08-22 | 2015-03-04 | 고려대학교 산학협력단 | Kit for determining infection of influenza A virus |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tian et al. | A fully automated centrifugal microfluidic system for sample-to-answer viral nucleic acid testing | |
KR101368463B1 (en) | Device for amplify nucleic acid comprising two heating block | |
KR101456646B1 (en) | Kit and method for detecting food-borne bacteria | |
RU2385940C1 (en) | Method for real-time detection of nucleic acids by polymerase chain reaction and device for implementation thereof | |
CA2682761C (en) | Methods for rapid multiplexed amplification of target nucleic acids | |
CN106661533B (en) | Multiplex PCR chip and multiplex PCR device comprising same | |
JP3899360B2 (en) | DNA amplification equipment | |
KR101483493B1 (en) | PCR device for detecting food-borne bacteria, and and method for detecting food-borne bacteria using the same | |
US9399793B2 (en) | Device for detecting nucleic acids | |
JP2005204592A (en) | Full automatic gene-analyzing system | |
KR102078085B1 (en) | High-speed real-time PCR device based on lap-on-a-chip for detecting food-borne bacteria to agrifood, and method for detecting food-borne bacteria to agrifood using the same | |
KR101835073B1 (en) | Fluidic PCR chip comprising heating block of repetitively disposed heater unit and PCR apparatus comprising the same | |
KR20130081948A (en) | Kit and method for detecting new influenza a virus | |
KR20130086893A (en) | Device for polymerase chain reaction to amplify nucleic acid comprising light transmitting heating block | |
KR102028381B1 (en) | PCR device using the primer set for detecting food-borne bacteria, and method for detecting food-borne bacteria using the same | |
KR20130134040A (en) | Pcr device for detecting foot-and-mouth disease by serotype, and method for detecting foot-and-mouth disease using the same | |
US20210053059A1 (en) | High-speed polymerase chain reaction analysis plate | |
KR20130091025A (en) | Pcr device for detecting new influenza a virus, and method for detecting new influenza a virus using the same | |
KR20130091027A (en) | Pcr device for detecting mycobacterium tuberculosis, and method for detecting mycobacterium tuberculosis using the same | |
KR101544089B1 (en) | Micro chip for detecting food-borne bacteria, real-time PCR device comprising the same, and method for detecting food-borne bacteria using the same | |
KR20180023545A (en) | Primer and Probe Set for Detecting Atypical Pneumonia, PCR Device Using Same, and Method for Detecting Atypical Pneumonia | |
KR20180023544A (en) | Primer and Probe Set for Detecting Typical Pneumonia, PCR Device Using Same, and Method for Detecting Typical Pneumonia | |
KR20130091026A (en) | Pcr device for detecting mycobacterium tuberculosis, and method for detecting mycobacterium tuberculosis using the same | |
KR20120045909A (en) | Apparatus and method for detecting multiplex target nucleic acids in real time | |
KR20130085227A (en) | Pcr device for detecting foot-and-mouth disease, and method for detecting foot-and-mouth disease using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Withdrawal due to no request for examination |